Update
$Aldeyra Therapeutics (ALDX.US)$ Aldeyra: No Safety Signals Observed in Clinical Trial, and Reproxalap Was Observed to Be Well Tolerated
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
annna : Is this good news? Why is the stock suspended?
Trytosaveabit OP annna : Yes it’s great news because now they have the data to submit to FDA for nBLA! Primary endpoint of trial was met! So they halt to allow all to have a chance to see the news at the same time